BioSpace News Archive

BioGX Announces Availability of Xfree PCR Reagents for Monkeypox

To address the growing need for simplified, rapid testing for Monkeypox, BioGX, a global provider of easy molecular diagnostic solutions, announced availability of Xfree PCR reagents for Sample-to-Answer Direct Sample PCR on multiple real-time PCR platforms including BioGX’s rapid “pixl” platform.

October 20, 2022
·
2 min read
Cell-Based Assays Market Size to Hit USD 34.8 Billion by 2030

According to Nova one advisor, the global Cell-based Assays market size is expected to hit around USD 34.8 billion by 2030 from valued at USD 15.95 billion in 2021 and growing at a CAGR of 8.75% from 2022 to 2030

October 20, 2022
·
9 min read
Pharm Country

Venatorx Pharmaceuticals Presents Data on Investigational Cefepime-Taniborbactam at IDWeek 2022

Venatorx Pharmaceuticals today will present new data during IDWeek 2022 for its novel investigational antibiotic cefepime-taniborbactam.

October 20, 2022
·
7 min read
Biotech Bay

Tivic Health’s CEO, Jennifer Ernst, to Present at Upcoming ThinkEquity Conference in New York City

Tivic Health’s CEO, Jennifer Ernst, to Present at Upcoming ThinkEquity Conference in New York City.

October 20, 2022
·
2 min read
BioMidwest

Inspire Medical Systems, Inc. Expands Therapy Access to Thousands of Federal Medical Facilities Through SDVOSB Partner, Lovell Government Services, Inc.

Inspire Medical Systems, Inc. and Lovell® Government Services, Inc. announced that they have partnered to provide the Inspire therapy system to Federal Healthcare Systems.

October 20, 2022
·
4 min read
Pharm Country

Promontory Therapeutics Receives U.S. Patent for Therapeutic Applications of PT-112 as an Immuno-Modulatory Agent

Promontory Therapeutics Inc. today announced the United States Patent and Trademark Office has issued a patent covering therapeutic applications of its lead compound, PT-112, as an immuno-modulatory agent, both as a monotherapy and in combination with other immunotherapy approaches.

October 20, 2022
·
4 min read
Deals

AbbVie Acquires DJS Antibodies, Further Strengthening Immunology Pipeline

AbbVie (NYSE: ABBV) today announced the acquisition of DJS Antibodies Ltd (“DJS”), a privately-held UK-based biotechnology company dedicated to discovering and developing antibody medicines that target difficult-to-drug disease-causing proteins, such as G protein-coupled receptors (GPCRs).

October 20, 2022
·
5 min read
Business

PacBio Launches Single-Cell Transcriptome Solution Ushering in a New Era of RNA Discovery

PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced the launch of its Multiplexed Arrays Sequencing (MAS-Seq) kit in partnership with the Broad Institute of MIT and Harvard and 10x Genomics, Inc.

October 20, 2022
·
5 min read
BioMidwest

Lazurite™ to be Showcased at the Medtech Industry’s Leading Event as One of the Industry’s Hottest Companies

Medical device and technology company Lazurite™ will be one of 50 early and mid-stage device, diagnostic and digital health companies participating in the 2022 MedTech Innovator Showcase at The MedTech Conference, powered by AdvaMed, Oct. 24-26 in Boston.

October 20, 2022
·
4 min read
Business

Michael Blum joins SeqOne Genomics to Head the Company’s Research and Development

SeqOne Genomics, announced that Michael Blum, Ph.D. is joining the company to lead its research and development department.

October 20, 2022
·
2 min read